These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17620384)

  • 21. Deciphering colistin heteroresistance in Acinetobacter baumannii clinical isolates from Wenzhou, China.
    Chen L; Lin J; Lu H; Zhang X; Wang C; Liu H; Zhang X; Li J; Cao J; Zhou T
    J Antibiot (Tokyo); 2020 Jul; 73(7):463-470. PubMed ID: 32152526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The combination of colistin and doripenem is synergistic against Klebsiella pneumoniae at multiple inocula and suppresses colistin resistance in an in vitro pharmacokinetic/pharmacodynamic model.
    Deris ZZ; Yu HH; Davis K; Soon RL; Jacob J; Ku CK; Poudyal A; Bergen PJ; Tsuji BT; Bulitta JB; Forrest A; Paterson DL; Velkov T; Li J; Nation RL
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5103-12. PubMed ID: 22802247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro antimicrobial activity and mutant prevention concentration of colistin against Acinetobacter baumannii.
    Cai Y; Li R; Liang B; Bai N; Liu Y; Wang R
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3998-9. PubMed ID: 20585134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates.
    Owen RJ; Li J; Nation RL; Spelman D
    J Antimicrob Chemother; 2007 Mar; 59(3):473-7. PubMed ID: 17289768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains.
    Li J; Nation RL; Owen RJ; Wong S; Spelman D; Franklin C
    Clin Infect Dis; 2007 Sep; 45(5):594-8. PubMed ID: 17682994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection.
    Cheah SE; Wang J; Nguyen VT; Turnidge JD; Li J; Nation RL
    J Antimicrob Chemother; 2015 Dec; 70(12):3291-7. PubMed ID: 26318190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple heteroresistance to tigecycline and colistin in Acinetobacter baumannii isolates and its implications for combined antibiotic treatment.
    Jo J; Kwon KT; Ko KS
    J Biomed Sci; 2023 Jun; 30(1):37. PubMed ID: 37287044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of efflux to colistin heteroresistance in a multidrug resistant Acinetobacter baumannii clinical isolate.
    Machado D; Antunes J; Simões A; Perdigão J; Couto I; McCusker M; Martins M; Portugal I; Pacheco T; Batista J; Toscano C; Viveiros M
    J Med Microbiol; 2018 Jun; 67(6):740-749. PubMed ID: 29717972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elucidating the Pharmacokinetics/Pharmacodynamics of Aerosolized Colistin against Multidrug-Resistant Acinetobacter baumannii and Klebsiella pneumoniae in a Mouse Lung Infection Model.
    Lin YW; Zhou QT; Han ML; Chen K; Onufrak NJ; Wang J; Turnidge JD; Howden BP; Forrest A; Chan HK; Li J
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29229637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutant prevention concentration of colistin alone and in combination with rifampicin for multidrug-resistant Acinetobacter baumannii.
    Nordqvist H; Nilsson LE; Claesson C
    Eur J Clin Microbiol Infect Dis; 2016 Nov; 35(11):1845-1850. PubMed ID: 27510182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.
    Bae S; Kim MC; Park SJ; Kim HS; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6774-6779. PubMed ID: 27600048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activities of vancomycin-containing regimens against colistin-resistant Acinetobacter baumannii clinical strains.
    O'Hara JA; Ambe LA; Casella LG; Townsend BM; Pelletier MR; Ernst RK; Shanks RM; Doi Y
    Antimicrob Agents Chemother; 2013 May; 57(5):2103-8. PubMed ID: 23422916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colistin resistance in a clinical Acinetobacter baumannii strain appearing after colistin treatment: effect on virulence and bacterial fitness.
    López-Rojas R; McConnell MJ; Jiménez-Mejías ME; Domínguez-Herrera J; Fernández-Cuenca F; Pachón J
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4587-9. PubMed ID: 23836165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii.
    Luque S; Grau S; Valle M; Sorlí L; Horcajada JP; Segura C; Alvarez-Lerma F
    Int J Antimicrob Agents; 2013 Aug; 42(2):178-81. PubMed ID: 23769664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies.
    Cai Y; Chai D; Wang R; Liang B; Bai N
    J Antimicrob Chemother; 2012 Jul; 67(7):1607-15. PubMed ID: 22441575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of carbonyl cyanide 3-chlorophenylhydrazone (CCCP) on killing Acinetobacter baumannii by colistin.
    Park YK; Ko KS
    J Microbiol; 2015 Jan; 53(1):53-9. PubMed ID: 25557480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High rate of colistin dependence in Acinetobacter baumannii.
    Hong YK; Lee JY; Wi YM; Ko KS
    J Antimicrob Chemother; 2016 Aug; 71(8):2346-8. PubMed ID: 27076109
    [No Abstract]   [Full Text] [Related]  

  • 38. Novel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumannii.
    Yadav R; Landersdorfer CB; Nation RL; Boyce JD; Bulitta JB
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2286-98. PubMed ID: 25645842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates.
    Peck KR; Kim MJ; Choi JY; Kim HS; Kang CI; Cho YK; Park DW; Lee HJ; Lee MS; Ko KS
    J Med Microbiol; 2012 Mar; 61(Pt 3):353-360. PubMed ID: 22016557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two types of colistin heteroresistance in
    Hong YK; Kim H; Ko KS
    Emerg Microbes Infect; 2020 Dec; 9(1):2114-2123. PubMed ID: 32897166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.